Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.550
-0.020 (-0.44%)
At close: May 29, 2026, 4:00 PM EDT
4.555
+0.005 (0.11%)
After-hours: May 29, 2026, 5:40 PM EDT
Aclaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $11 | Buy | Maintains | $11 | +141.76% | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $12 | Buy | Reiterates | $12 | +163.74% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +251.65% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $10 | Buy | Maintains | $10 | +119.78% | May 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +119.78% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $4 | Hold | Maintains | $4 | -12.09% | May 8, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $10 | Buy | Maintains | $10 | +119.78% | May 7, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains $10 | Buy | Maintains | $10 | +119.78% | Apr 16, 2026 |